TARDBP and amyotrophic lateral sclerosis: Starting from patient‐derived fibroblasts, we generated iPSCs from three ALS patients carrying heterozygous point mutations in TARDBP: one with a G287S mutation, one with a N390S mutation, and one carrying both an A382T mutation and a C9ORF72 repeat expansion (Appendix Table S1).